Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | Arrowhead Publishers | The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007

The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007

With a market size of US$14.5 billion in 2005 and an anticipated value of US$16.5 billion in 2006, the neurodegenerative market represents a valuable, fast-growing opportunity in the pharma/biotech industry. An increase in the number of aged people, increased life expectancy, unmet clinical needs together with advances in treatments of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease will continue to contribute to the expansion of the global market.

This report provides an insight into the neurodegenerative market, neurotherapeutic drugs currently available, and upcoming products. This report specifically focuses on key CNS diseases, such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, Huntington’s disease, and neuropathies. Profiles of leading companies that are active in R&D in these areas are included.

The report presents, in detail, an overview of the current global market for neurodegenerative drugs for selected neurological diseases, including currently marketed and forthcoming neurotherapeutic products. Market analysis and assessment for key neurodegenerative therapies is done across major pharmaceutical markets in United States (US)/North America, Europe and Japan.

Key features of this report:

Statistical information for selected neurological diseases

Overview of the disease, key therapies, market size and growth, market composition by region, as well as market outlook and forecast

Global sales figures for key neurodegenerative therapies

Financial forecasts by disease and key product

Description of neurotherapeutic products currently on the market, including a description of products in the pipeline

Company profiles of major pharmaceutical providers active in R&D in these areas

The report also deals with factors affecting growth, new drug therapies, and clinical research in the completion stages.

The diseases/conditions addressed in the report include:

Alzheimer’s disease

Parkinson’s disease

Multiple sclerosis

Amyotrophic lateral sclerosis

Huntington’s disease

Neuropathies

Publication Date: January 31, 2007 Format PDF
Table of Contents

Price

Single User PDF $2250.00

Site Licence PDF $4499.00

Corporate Wide Licence PDF $5499.00

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions